Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

Published:2023-04-27 Issue:8 Volume:42 Page:e290-e292
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Bermejo-Gómez Amanda¹^ORCID,Aguilera-Alonso David¹²,Rincón-López Elena María¹²,Catalán-Alonso Pilar³,Bardón-Cancho Eduardo J.⁴,García-Morín Marina⁴,Manrique-Rodríguez Silvia⁵,Navarro-Gómez María Luisa¹²

Affiliation:

1. Department of Pediatrics, Infectious Diseases Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

2. Biomedical Research Networking Center on Infectious Diseases (CIBERINFEC), Instituto Carlos III, Madrid, Spain

3. Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain

4. Department of Pediatrics, Pediatric Hematology Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain

5. Department of Pharmacy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Abstract

We describe the use of monoclonal antibodies for the treatment of persistent SARS-CoV-2 infection in a pediatric patient with severe combined immunodeficiency who required urgent stem cell transplantation to cure his disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference10 articles.

1. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study.;Meyts;J Allergy Clin Immunol,2021

2. SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency.;Van Oers;Clin Immunol,2021

3. Persistent viral shedding after sars-cov-2 infection in an infant with severe combined immunodeficiency.;Hariharan;Indian J Pediatr,2022

4. SARS-CoV-2-related acute respiratory distress syndrome uncovers a patient with severe combined immunodeficiency disease.;Al-Saud;J Clin Immunol,2021

5. Case report: convalescent plasma achieves SARS-CoV-2 viral clearance in a patient with persistently high viral replication over 8 weeks due to severe combined immunodeficiency (scid) and graft failure.;Keitel;Front Immunol,2021